Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral stem cell transplantation

Cell Transplantation ◽

Antibody Therapy ◽

High Dose ◽

High Dose Therapy ◽

Peripheral Stem Cell Transplantation ◽

Anti Cd20

Progressive Intermediate-Grade Non-Hodgkin's Lymphoma After High-Dose Therapy and Autologous Peripheral Stem-Cell Transplantation: Changing the Natural History with Monoclonal Antibody Therapy

Clinical Lymphoma ◽

10.3816/clm.2000.n.006 ◽

2000 ◽

Vol 1 (1) ◽

pp. 62-66 ◽

Cited By ~ 6

Author(s):

Donald E. Tsai ◽

Stephen J. Schuster ◽

Alexander Matthies ◽

Halle C.F. Moore ◽

Abass Alavi ◽

...

Keyword(s):

Monoclonal Antibody ◽

Stem Cell ◽

Natural History ◽

Cell Transplantation ◽

Antibody Therapy ◽

High Dose ◽

High Dose Therapy ◽

Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1703371 ◽

2002 ◽

Vol 29 (4) ◽

pp. 365-366 ◽

Cited By ~ 23

Author(s):

A Ship ◽

W May ◽

K Lucas

Keyword(s):

Monoclonal Antibody ◽

Stem Cell ◽

T Cell ◽

Cell Transplantation ◽

Hemolytic Anemia ◽

Autoimmune Hemolytic Anemia ◽

Antibody Therapy ◽

Anti Cd20

rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1704899 ◽

2005 ◽

Vol 35 (9) ◽

pp. 903-907 ◽

Cited By ~ 8

Author(s):

M Hunault-Berger ◽

A Tanguy-Schmidt ◽

P Rachieru ◽

V Lévy ◽

M Truchan-Graczyk ◽

...

Keyword(s):

Stem Cell ◽

Pilot Study ◽

Blood Cell ◽

Cell Transplantation ◽

Red Blood Cell ◽

Red Blood Cell Transfusion ◽

High Dose ◽

High Dose Therapy ◽

Monoclonal Antibody Therapy with Autologous Peripheral Blood Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Cancer Control ◽

10.1177/107327480200900202 ◽

2002 ◽

Vol 9 (2) ◽

pp. 99-105 ◽

Cited By ~ 3

Author(s):

Ivan Aksentijevich ◽

Ian W. Flinn

Keyword(s):

Monoclonal Antibody ◽

Stem Cell ◽

Cell Transplantation ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

Antibody Therapy ◽

Blood Stem Cell ◽

Blood Stem Cell Transplantation

The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]

Blood ◽

10.1182/blood.v77.2.211.bloodjournal772211 ◽

1991 ◽

Vol 77 (2) ◽

pp. 211-213 ◽

Cited By ~ 2

Author(s):

A Kessinger ◽

JO Armitage

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Peripheral Stem Cell ◽

The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]

Blood ◽

10.1182/blood.v77.2.211.211 ◽

1991 ◽

Vol 77 (2) ◽

pp. 211-213 ◽

Cited By ~ 199

Author(s):

A Kessinger ◽

JO Armitage

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Peripheral Stem Cell ◽

Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation

Annals of Hematology ◽

10.1007/s00277-001-0397-4 ◽

2001 ◽

Vol 81 (2) ◽

pp. 119-123 ◽

Cited By ~ 18

Author(s):

C. Gemmel ◽

F. Cremer ◽

M. Weis ◽

M. Witzens ◽

G. Moldenhauer ◽

...

Keyword(s):

Stem Cell ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Consolidation Therapy ◽

Cell Leukemia ◽

High Dose Therapy ◽

Primary Plasma Cell Leukemia ◽

Cd20 Antibody ◽

Anti Cd20

A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)

Annals of Hematology ◽

10.1007/s00277-002-0495-y ◽

2002 ◽

Vol 81 (8) ◽

pp. 424-429 ◽

Cited By ~ 10

Author(s):

J.-P. Glossmann ◽

A. Josting ◽

B. Pfistner ◽

U. Paulus ◽

A. Engert

Keyword(s):

Stem Cell ◽

Randomized Trial ◽

Cell Transplantation ◽

Hodgkin’S Disease ◽

Single Agent ◽

High Dose Chemotherapy ◽

High Dose ◽

Peripheral Stem Cell ◽

Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation

Blood ◽

10.1182/blood-2002-07-2030 ◽

2002 ◽

Vol 100 (7) ◽

pp. 2679-2680 ◽

Cited By ~ 22

Author(s):

Anne Wiesmann ◽

Robert Weissert ◽

Lothar Kanz ◽

Hermann Einsele

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Autologous Blood ◽

High Dose ◽

High Dose Therapy ◽

Long Term Follow Up ◽

Blood Stem Cell Transplantation

Salvage autologous hematopoietic stem cell transplantation for multiple myeloma performed with stem cells procured after previous high dose therapy – a multicenter report by the Polish Myeloma Study Group

Leukemia & Lymphoma ◽

10.1080/10428194.2021.1950712 ◽

2021 ◽

pp. 1-9

Author(s):

Joanna Drozd-Sokołowska ◽

Anna Waszczuk-Gajda ◽

Przemysław Biecek ◽

Katarzyna Kobylińska ◽

Joanna Mańko ◽

...

Keyword(s):

Stem Cells ◽

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Cell Transplantation ◽

High Dose ◽

Study Group ◽

High Dose Therapy ◽

Hematopoietic Stem